Skip to main content

Table 4 Performance characteristics of biomarkers significantly different in dengue fever following adjustment for multiple comparisons

From: Host biomarkers distinguish dengue from leptospirosis in Colombia: a case–control study

 

AUC (95% CI)

Cut-off*

Sensitivity (95% CI)

Specificity (95% CI)

Positive LR (95% CI)

Negative LR (95% CI)

Angiopoietin-like 3

0.81 (0.74–0.87)

>135.75

84.1 (76.0–90.3)

63.8 (48.5–77.3)

2.3 (1.8–2.9)

0.3 (0.1–0.5)

IL-18BP

0.92 (0.87–0.96)

>24.52

94.7 (88.8–98.0)

83.0 (69.2–92.4)

5.6 (4.9–6.4)

0.06 (0.02–0.2)

CXCL10

0.84 (0.77–0.89)

>0.96

82.3 (74.0–88.8)

72.3 (57.4–84.4)

2.9 (2.4–3.6)

0.2 (0.1–0.5)

Platelet Factor 4 a

0.69 (0.61–0.76)

>29.98 a

39.8 (30.7–49.5)

97.9 (88.7–99.9)

18.7 (14.9–23.6)

0.6 (0.1–4.3)

sICAM-1

0.84 (0.77–0.89)

>285.9

83.2 (75.0–89.6)

78.7 (64.3–89.3)

3.9 (3.3–4.6)

0.2 (0.1–0.4)

Factor D

0.85 (0.79–0.90)

>1248.1

69.0 (59.6–77.4)

93.6 (82.5–98.7)

10.8 (9.4–12.5)

0.3 (0.1–1.1)

sEng

0.92 (0.86–0.96)

>9.12

79.7 (71.0–86.6)

93.6 (82.5–98.7)

12.5 (11.1–14.1)

0.2 (0.07–0.7)

sKDR

0.71 (0.64–0.78)

>5.18

84.1 (76.0–90.3)

51.1 (36.1–65.9)

1.7 (1.3–2.3)

0.3 (0.2–0.5)

sTie-2

0.73 (0.65–0.80)

≤ 9.18

72.6 (63.4–80.5)

68.1 (52.9–80.9)

2.3 (1.8–2.9)

0.4 (0.2–0.7)

  1. *Concentration in ng/mL unless otherwise indicated, aμg/mL.
  2. ROC curve analysis- non-parametric analysis by method of Delong et al. with the confidence interval estimated using binomial.